Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just blinked an eye I think - back into REM now it seems.
is this sleeping giant waking up?
Ok I’m on finally. 2 lots of 15k buys not loads but it’s enough for now .
Paid 50.978 if you see them as sells they are buys
I’m in sng / Avct /Odx /!hemo / Ncyt / gdr couldn’t leave this out. I’m in the others for a lot more. Let’s We how this goes before i commit anymore.
Good to meet you all.
Hi Trek,
I take your point with ref to microbiome, but it is there.
I am at odds with your cash call with regards OPTI. Just £3m since IPO, and then the revenues comment. This I agree with to a degree, but I am sure of the period in which your point refers to. I think it's fair to say OPTI developed revenues 18-24 months later than MOST PI's expected, but that is not the same as OPTI promising.
I am learning all the time with regards the science 4D platforms have. However, pharma routes are notorious for high failure rates, especially toxicity. 4D looks good in this regard, so some serious mitigation here.
If I had a complaint about 4D it would be the priority apportioning funds to the most likely success and build from there. I agree it has multiple shots at goal, but the stadia has proved expensive for retail investors with something like £167m raised since listing.
I will have a look at ONC.
Hi elrico,
Oh the irony, I held OPTI for a couple of years but eventually got despondent as didn’t see the rev’s coming through and then the last cash call was the last straw. I am very dubious now of companies quoting addressable market size as xbillion £’s to ostensibly inflate their worth.
The link between 4D and Opti is tenuous outside of the microbiome. I think OPTI’s science is sound, the CEO Stephen O’ is pretty good but the products are expensive and during a lock down or recession I want chocolate not a strawberry health shake that makes me feel full.
At least with 4D we know if we don’t have money we have to raise it and we have multiple shots on goal for a big prize many times our mcap from just a few customers rather than waiting on royalties from so many global partners tied in with min sales objectives. You get the gist there are distinct differences but I am glad holders there are over the 50p again as the sell off was over done.
O&W,
If you are keen to check out a biotech that will help folk check out ONC. Oncimmune.
They have an early lung test that will pick up cancer antibodies in blood and have been clinically proven to identify lung cancer 4 years in advance! The phase three trial was the biggest in the world at over 12000 pts.
They are running another trial in China, results Q1 21 and in Moscow, a really big trial for smokers. Revs will follow. Given the Scotland trials I can’t see it failing.
They have extended the platform for early prostrate, lung, liver, ovarian and breast cancer. A 4 year notice! Imagine that for the most common cancers. These are yet to be released but liver is ready.
They have big Pharma deals, they are using the platform to tailor and target drugs in advance as they can make massive savings. Roche have just extended and NHS use them amongst other.. Mrs Trek is a breast cancer survivor hence my interest there.
CEO Adam Hill has replied to my emails. Great PI engagement. MCAP £88m and just, temporarily broke out of TA resistance. Also funded and make acquisitions with distribution kicking off in US and Brazil.
Downside is hardly anyone has heard of them, BB very quiet. Check through the RNS’s and proactive interviews. I think you’ll like. I am v pleased to be invested there.
ATB
Trek
Older but not wise, for sure. The article wasn't about skincare, it was as well as and the microbiome and how two very different companies approach it for our wellbeing. It also put some BS in its rightful place and it was written without the purpose of confirmation bias some fragile investors seem the need to suckle on.
Have you ever heard of critical thought or did the leftwaffe beat it out of you at University?
I am heartbroken you have filtered me one my very first post. Wow, you must be super fragile.
I bought into DDDD because the platform is an attempt to improve life, not for a skin cosmetic product. Filtered, everywhere you go.
That would be very welcome...assuming positively.
For those of you than don't mind a serious discussion...
https://lemminginvestors.blogspot.com/2020/08/4d-pharma-v-optibiotix-apples-pears-bbm.html
Waiting for the Biotherapeutic MRx4DP0004 to Treat COVID-19 result and it is due anytime soon.
Watch for an early news leak and this sp jumps.
The charts are also looking good as a buyer must be mopping these up.
The tweet is imminent, but who will it be? Dan the man??
Just be patient. This sp is a coiled spring just waiting to be released.
C.